医学信息
醫學信息
의학신식
Medical Information
2015年
44期
98-99
,共2页
普鲁卡因贯续支气管动脉栓塞术%大咯血%老年患者
普魯卡因貫續支氣管動脈栓塞術%大咯血%老年患者
보로잡인관속지기관동맥전새술%대각혈%노년환자
Procaine continued with bronchial artery embolization%Massive hemoptysis%Elderly patients
目的比较普鲁卡因贯续支气管动脉栓塞术与单纯支气管动脉栓塞术治疗老年性患者大咯血的临床疗效。方法63例老年性大咯血患者随机接受普鲁卡因贯续支气管动脉栓塞术与单纯支气管动脉栓塞术治疗,普鲁卡因贯续支气管动脉栓塞术27例,单纯支气管动脉栓塞术治36例。比较两组的止血率、死亡率、并发症,复发率和治疗费用。结果普鲁卡因贯续支气管动脉栓塞术治疗组中止血26例(96.30%),其中单纯应用普鲁卡因未行介入治疗15例(55.56%),支气管动脉栓塞组止血34例(94.44%),两组止血率、死亡率、复发率比较差异无显著性(>0.05)。普鲁卡因联合支气管动脉栓塞组治疗费用两组比较具有显著性差异(<0.05)。结论普鲁卡因贯续支气管动脉栓塞术可作为老年性大咯血的临床用首选药方案,其治疗费用明显下降。
目的比較普魯卡因貫續支氣管動脈栓塞術與單純支氣管動脈栓塞術治療老年性患者大咯血的臨床療效。方法63例老年性大咯血患者隨機接受普魯卡因貫續支氣管動脈栓塞術與單純支氣管動脈栓塞術治療,普魯卡因貫續支氣管動脈栓塞術27例,單純支氣管動脈栓塞術治36例。比較兩組的止血率、死亡率、併髮癥,複髮率和治療費用。結果普魯卡因貫續支氣管動脈栓塞術治療組中止血26例(96.30%),其中單純應用普魯卡因未行介入治療15例(55.56%),支氣管動脈栓塞組止血34例(94.44%),兩組止血率、死亡率、複髮率比較差異無顯著性(>0.05)。普魯卡因聯閤支氣管動脈栓塞組治療費用兩組比較具有顯著性差異(<0.05)。結論普魯卡因貫續支氣管動脈栓塞術可作為老年性大咯血的臨床用首選藥方案,其治療費用明顯下降。
목적비교보로잡인관속지기관동맥전새술여단순지기관동맥전새술치료노년성환자대각혈적림상료효。방법63례노년성대각혈환자수궤접수보로잡인관속지기관동맥전새술여단순지기관동맥전새술치료,보로잡인관속지기관동맥전새술27례,단순지기관동맥전새술치36례。비교량조적지혈솔、사망솔、병발증,복발솔화치료비용。결과보로잡인관속지기관동맥전새술치료조중지혈26례(96.30%),기중단순응용보로잡인미행개입치료15례(55.56%),지기관동맥전새조지혈34례(94.44%),량조지혈솔、사망솔、복발솔비교차이무현저성(>0.05)。보로잡인연합지기관동맥전새조치료비용량조비교구유현저성차이(<0.05)。결론보로잡인관속지기관동맥전새술가작위노년성대각혈적림상용수선약방안,기치료비용명현하강。
Objective To compare the ef icacies of the treatments of procaine continued with bronchial arterial embolization and purely bronchial arterial embolizationin on elderly patients with massive hemoptysis. Methods Sixty -three elderly patients with massive hemoptysis were divided into two groups randomly. Twenty-seven patients were treated by procaine continued with bronchial arterial embolization and the other 36 by purely bronchial arterial embolization. The curative rates,mortality,complications,relapsing rates and expenses were observed. Results The curative rate of procaine continued with bronchial arterial embolization was 96.30%,in which simple application of procaine was 55.56%. The curative rate of purely bronchial arterial embolization was 94.44%,The curative rates, mortality,complications and relapsing rates were no dif erence by comparison ( >0.05) . However, the cost of treatment was significantly dif erence ( <0.05). Conclusion Procaine continued with bronchial artery embolization was a massive hemoptysis clinical use prefer ed drug program, and the cost of treatment significantly decreased.